Compare up to 4 stocks side by side, across all 7 of StockIQ's scoring categories.
| Category | ADAG Adagene Inc. - ADS, each representing 1.25 | AAPG Ascentage Pharma Group International - American Depository |
|---|---|---|
| Price | $3.21 -4.7% | $15.86 +3.2% |
| StockIQ Score | 44D Weak Risk: High | 38F Weak Risk: Medium |
| Technical | 34F | 21F |
| Fundamental | — | 35F |
| Growth | — | 50C- |
| Fair Value | — | 38F |
| News | 68B- | 50C- |
| Quality | — | 50C- |
| Risk | 42D | 48D+ |
Scores are based on real financial data only and do not constitute investment advice. How the score is calculated
AAPG outperforms ADAG in available categories. Its investor score (37 vs. 30) and growth score (50) are notably higher, indicating stronger investor confidence and growth potential. AAPG also has a higher valuation score (38) compared to ADAG’s unavailable data, suggesting better perceived market value. Both share a "WEAK" rating, but AAPG’s technical score (18 vs. 19) is slightly lower.
